Houston-based Whitsett Vision Group has become the first ophthalmology group in the country to perform a cataract surgery using a new FDA-approved lens, the Lenstec ClearView 3.
Whitsett has also added a second new lens for use in cataract procedures — the RxSight Light Adjustable Lens.
The ClearView 3 lens showed success for improving patient vision in clinical trials. The team at Whitsett first performed surgery using the lens last month.
"The ClearView 3 from Lenstec has been designed with increased precision, accuracy and stability, which results in excellent long-term visual outcomes at near, intermediate and distance," Jeffery Whitsett, MD, founder of the Whitsett Vision Group, said in a Sept. 26 press release.